Brandon Capital collects A$439 million for sixth fund

•

24 July 2025

•

Thierry Heles

Brandon Capital, an Australian venture capital firm focused on life sciences, has raised A$439 million¹ for its sixth fund, closing the vehicle considerably above its target size of A$350 million.

Limited partners in the Brandon BioCatalyst Fund Six include pension funds HESTA and Hostplus.

Keep reading with a free account. Sign up today.
Already a subscriber? Log in.

About the author

Thierry Heles is the founder and editor of The Next Leap. He has been writing about innovation ecosystems for 11+ years. To date, his research has featured in the UK Spinout Review, the Financial Times, and the Wall Street Journal.